Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Alemayehu WG"'
Autor:
Defilippi CR; Inova Heart and Vascular Institute, Falls Church, Virginia. Electronic address: Christopher.Defilippi@Inova.org., Alemayehu WG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada., Voors AA; University of Groningen, University Medical Center of Groningen, Groningen, the Netherlands., Kaye D; Baker Heart & Diabetes Institute, Melbourne, Australia., Blaustein RO; Merck & Co., Inc., Rahway, New Jersey., Butler J; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi., Ezekowitz JA; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada., Hernandez AF; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore., Roessig L; Bayer AG, Wuppertal, Germany., Seliger S; University of Maryland School of Medicine, Baltimore, Maryland., Shah P; Inova Heart and Vascular Institute, Falls Church, Virginia., Westerhout CM; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada., Armstrong PW; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada., O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia.
Publikováno v:
Journal of cardiac failure [J Card Fail] 2023 Apr; Vol. 29 (4), pp. 448-458. Date of Electronic Publication: 2023 Jan 09.
Autor:
Senni M; University of Milan - Bicocca, Milan, ASST Papa Giovanni XXIII, Bergamo, Italy., Alemayehu WG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada., Sim D; National Heart Centre, Singapore, Singapore., Edelmann F; Charite Universitätsmedizin, Berlin, Germany., Butler J; University of Mississippi Medical Center, Jackson, MS, USA., Ezekowitz J; Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada., Hernandez AF; Duke Clinical Research Institute, Durham, NC, USA., Lam CSP; National Heart Centre, Singapore, Singapore., O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA, USA., Pieske B; Charite Universitätsmedizin, Berlin, Germany., Ponikowski P; Wroclaw Medical University, Wroclaw, Poland., Roessig L; Bayer AG, Wuppertal, Germany., Voors AA; University Medical Center Groningen, Groningen, The Netherlands., Westerhout CM; Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada., McMullan C; Merck & Co., Inc., Kenilworth, NJ, USA., Armstrong PW; Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada.
Publikováno v:
European journal of heart failure [Eur J Heart Fail] 2022 Sep; Vol. 24 (9), pp. 1614-1622. Date of Electronic Publication: 2022 Jul 20.
Autor:
Ezekowitz JA; Division of Cardiology, Department of Medicine, Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada., O'Connor CM; Division of Cardiology, Department of Medicine, Duke Clinical Research Institute, Duke University, Durham, North Carolina; Inova Heart and Vascular Institute, Falls Church, Virginia., Troughton RW; Department of Medicine, University of Otago, Christchurch, New Zealand., Alemayehu WG; Division of Cardiology, Department of Medicine, Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada., Westerhout CM; Division of Cardiology, Department of Medicine, Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada., Voors AA; Department of Cardiology and Thorax Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Butler J; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi., Lam CSP; Department of Cardiology and Thorax Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Cardiology, National Heart Centre Singapore and Duke-National University of Singapore., Ponikowski P; Wroclaw Medical University, Department of Heart Disease, Wroclaw, Poland., Emdin M; Cardiothoracic Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy; and Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy., Patel MJ; Merck & Co. Inc., Kenilworth, New Jersey., Pieske B; Department of Internal Medicine-Cardiology, Charité University Medicine, German Heart Center, Berlin, Germany., Roessig L; Bayer AG, Wuppertal, Germany., Hernandez AF; Division of Cardiology, Department of Medicine, Duke Clinical Research Institute, Duke University, Durham, North Carolina., Armstrong PW; Division of Cardiology, Department of Medicine, Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada. Electronic address: parmstro@ualberta.ca.
Publikováno v:
JACC. Heart failure [JACC Heart Fail] 2020 Nov; Vol. 8 (11), pp. 931-939. Date of Electronic Publication: 2020 Oct 07.
Autor:
Howlett JG; Cumming School of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada., Sharma N; Cumming School of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada., Alemayehu WG; Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada., Dyck JRB; Department of Paediatrics, University of Alberta, Edmonton, Alberta, Canada., Anderson T; Cumming School of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada., Fine N; Cumming School of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada., Becker H; Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada., White JA; Cumming School of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada., Paterson DI; Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada., Thompson RB; Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, Canada., Oudit GY; Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada., Haykowsky MJ; Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada., Ezekowitz JA; Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
Publikováno v:
ESC heart failure [ESC Heart Fail] 2020 Oct; Vol. 7 (5), pp. 2725-2733. Date of Electronic Publication: 2020 Jun 27.
Autor:
Leeksma AC; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Taylor J; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu B; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Gardner JR; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., He J; Foundation Medicine, Inc., Cambridge, MA, USA., Nahas M; Foundation Medicine, Inc., Cambridge, MA, USA., Gonen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alemayehu WG; HOVON Data Center, Erasmus MC, Daniel Den Hoedkliniek, Rotterdam, The Netherlands., Te Raa D; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Walther T; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hüllein J; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Dietrich S; Department of Hematology, University Hospital Heidelberg, Heidelberg, Germany., Claus R; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Haematology/Oncology, Augsburg Hospital, Augsburg, Germany., de Boer F; Department of Internal medicine, Ikazia Hospital, Rotterdam, The Netherlands., de Heer K; Department of Internal medicine, Flevo Hospital, Almere, The Netherlands., Dubois J; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Dampmann M; Department of Haematology, University Hospital Essen, Essen, Germany., Dürig J; Department of Haematology, University Hospital Essen, Essen, Germany., van Oers MHJ; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Geisler CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Eldering E; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Levine RL; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Miller V; Foundation Medicine, Inc., Cambridge, MA, USA., Mughal T; Foundation Medicine, Inc., Cambridge, MA, USA., Lamanna N; Department of Medicine, Columbia University Medical Center, New York, USA., Frattini MG; Department of Medicine, Columbia University Medical Center, New York, USA., Heaney ML; Department of Medicine, Columbia University Medical Center, New York, USA., Zelenetz A; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zenz T; Department of Molecular Therapy in Haematology & Oncology, German Cancer Research Center (dkfz) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Haematology, University Hospital Zürich and University of Zürich, Zürich, Switzerland., Abdel-Wahab O; Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. abdelwao@mskcc.org., Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands. a.p.kater@amc.uva.nl.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands. a.p.kater@amc.uva.nl.
Publikováno v:
Leukemia [Leukemia] 2019 Feb; Vol. 33 (2), pp. 390-402. Date of Electronic Publication: 2018 Jul 23.
Autor:
Vojdeman FJ; a Department of Hematology , Rigshospitalet , Copenhagen , Denmark.; b Department of Clinical Biochemistry , Bispebjerg-Frederiksberg Hospital , Copenhagen , Denmark., Herman SEM; c Hematology Branch, National Heart, Lung, and Blood Institute , National Institutes of Health , Bethesda , MD , USA., Kirkby N; d Department of Microbiology , Rigshospitalet , Copenhagen , Denmark., Wiestner A; c Hematology Branch, National Heart, Lung, and Blood Institute , National Institutes of Health , Bethesda , MD , USA., van T' Veer MB; e Department of Hematology , Leiden University Medical Centre , Leiden , The Netherlands., Tjønnfjord GE; f Department of Hematology , Oslo University Hospital and Institute of Clinical Medicine, University of Oslo , Oslo , Norway., Itälä-Remes MA; g Department of Hematology , Turku Central University Hospital , Turku , Finland., Kimby E; h Division of Hematology, Department of Medicine at Huddinge , Karolinska Institute , Stockholm , Sweden., Farooqui MZ; c Hematology Branch, National Heart, Lung, and Blood Institute , National Institutes of Health , Bethesda , MD , USA., Polliack A; i Department of Hematology , Hadassah University Hospital, Hebrew University Medical School , Jerusalem , Israel., Wu KL; j Department of Hematology , Stuivenberg Hospital , Antwerpen , Belgium., Doorduijn JK; k Department of Hematology , Erasmus MC Cancer Center , Rotterdam , The Netherlands., Alemayehu WG; l HOVON Data Centre, Erasmus MC , Rotterdam , The Netherlands., Wittebol S; m Department of Internal Medicine , Gelderse Vallei Hospital , Amersfoort , The Netherlands., Kozak T; n Department of Clinical Hematology, Third Faculty of Medicine , Charles University Hospital Kralovske Vinohrady , Prague , Czech Republic., Walewski J; o Lymphoid Malignancies , Maria Sklodowska - Curie Memorial Institute and Oncology Centre , Warszawa , Poland., Abrahamse-Testroote MCJ; l HOVON Data Centre, Erasmus MC , Rotterdam , The Netherlands., van Oers MHJ; p Department of Hematology , Academisch Medisch Centrum , Amsterdam , The Netherlands., Geisler CH; a Department of Hematology , Rigshospitalet , Copenhagen , Denmark., Niemann CU; a Department of Hematology , Rigshospitalet , Copenhagen , Denmark.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2017 Oct; Vol. 58 (10), pp. 2356-2362. Date of Electronic Publication: 2017 Feb 07.
Autor:
Vojdeman FJ; a Department of Hematology , Rigshospitalet , Copenhagen , Denmark., Van't Veer MB; b Department of Hematology , Leiden University Medical Centre , Leiden , The Netherlands., Tjønnfjord GE; c Department of Hematology , Oslo University Hospital and Institute of Clinical Medicine, University of Oslo , Oslo , Norway., Itälä-Remes M; d Turku Central University Hospital , Turku , Finland., Kimby E; e Division of Hematology, Department of Medicine at Huddinge , Karolinska Institute , Stockholm , Sweden., Polliack A; f Department of Hematology , Hadassah University Hospital, Hebrew University Medical School , Jerusalem , Israel., Wu KL; g Department of Hematology , Stuivenberg Hospital , Antwerpen , Belgium., Doorduijn JK; h Department of Hematology , Erasmus MC Cancer Center , Rotterdam , The Netherlands., Alemayehu WG; i HOVON Data Centre, Erasmus MC , Rotterdam , The Netherlands., Wittebol S; j Department of Internal Medicine , Gelderse Vallei, Amersfoot , The Netherlands., Kozak T; k Department of Clinical Hematology, Third Faculty of Medicine , Charles University Hospital Kralovske Vinohrady , Prague , Czech Republic., Walewski J; l Lymphoid Malignancies , Maria Sklodowska-Curie Memorial Institute and Oncology Centre , Warszawa , Poland., Abrahamse-Testroote MC; i HOVON Data Centre, Erasmus MC , Rotterdam , The Netherlands., van Oers MH; m Department of Hematology , Academisch Medisch Centrum , Amsterdam , The Netherlands., Geisler CH; a Department of Hematology , Rigshospitalet , Copenhagen , Denmark.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2017 Mar; Vol. 58 (3), pp. 594-600. Date of Electronic Publication: 2016 Aug 02.
Autor:
Aluwini S; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: s.aluwini@erasmusmc.nl., Busser WM; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Baartman LE; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Bhawanie A; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Alemayehu WG; Clinical Trials Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Boormans JL; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kolkman-Deurloo IK; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Brachytherapy [Brachytherapy] 2016 Nov - Dec; Vol. 15 (6), pp. 707-713. Date of Electronic Publication: 2016 Jun 28.
Autor:
van Diepen S; Divisions of Critical Care and Cardiology, University of Alberta, Edmonton, AB, Canada. sv9@ualberta.ca.; Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada. sv9@ualberta.ca.; 2C2 Cardiology Walter MacKenzie Center, University of Alberta Hospital, 8440-11 St., Edmonton, AB, T6G 2B7, Canada. sv9@ualberta.ca., Alemayehu WG; Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada., Zheng Y; Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada., Theroux P; Institut de Cardiologie de Montréal, Université de Montréal, Québec, Canada., Newby LK; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA., Mahaffey KW; Stanford University Medical Center, Stanford University School of Medicine, Stanford, CA, USA., Granger CB; Institut de Cardiologie de Montréal, Université de Montréal, Québec, Canada., Armstrong PW; Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada.; Division of Cardiology, University of Alberta, Edmonton, AB, Canada.
Publikováno v:
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2016 Oct; Vol. 42 (3), pp. 376-85.
Autor:
Incrocci L; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. Electronic address: l.incrocci@erasmusmc.nl., Wortel RC; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Alemayehu WG; Clinical Trials Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Aluwini S; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Schimmel E; Radiotherapy Group, Institute for Radiation Oncology, Arnhem, Netherlands., Krol S; Department of Radiation Oncology, Leiden University Medical Centre, Leiden, Netherlands., van der Toorn PP; Department of Radiation Oncology, Catharina Hospital, Eindhoven, Netherlands., Jager H; Radiotherapy Centre West, The Hague, Netherlands., Heemsbergen W; Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Heijmen B; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Pos F; Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2016 Aug; Vol. 17 (8), pp. 1061-1069. Date of Electronic Publication: 2016 Jun 20.